New Patient Appointment or 214-645-8300

Mitral Valve Regurgitation

TAVR is not the ‘beginning of the end’ for aortic stenosis open heart surgery

Two studies presented in March at #ACC19 are the talk of the cardiology community. Both address one question: Can low-risk patients with aortic stenosis benefit from TAVR? Dharam Kumbhani, M.D., says the data are intriguing, but the excitement is a bit premature. Learn more.

Dharam Kumbhani, M.D. / Anthony Bavry, M.D.

November 4, 2021

MitraClip therapy: Which patients are ‘sick enough’?

MitraClip has emerged as a treatment option for patients with mitral valve disease who are not healthy enough for valve replacement surgery. However, the device is approved for only a small patient pool – and it might be unnecessary with optimized medical therapy.

Dharam Kumbhani, M.D.

February 20, 2019